Kabra Drugs Ltd.
BSE: 524322 | Sector: Health care |
NSE: N.A. | ISIN Code: INE323K01017 |
BSE 00:00 | 03 Feb | 4.83 |
0.23 (5.00%) |
OPEN
4.83 |
HIGH
4.83 |
LOW
4.83 |
NSE 05:30 | 01 Jan | Kabra Drugs Ltd |
OPEN | 4.83 |
PREVIOUS CLOSE | 4.60 |
VOLUME | 298 |
52-Week high | 5.70 |
52-Week low | 2.95 |
P/E | |
Mkt Cap.(Rs cr) | 2 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Kabra Drugs Ltd. (KABRADRUGS) - Balance Sheet
Figures in Rs crore | 2022 | 2021 | 2020 |
Sources of Funds | |||
Share Capital | 4.39 | 4.39 | 4.39 |
Reserves | -4.78 | -4.60 | -4.42 |
Total Shareholders Funds | -0.39 | -0.21 | -0.03 |
Secured Loans | 0.00 | 0.00 | 0.00 |
Unsecured Loans | 1.03 | 0.90 | 0.65 |
Total Debt | 1.03 | 0.90 | 0.65 |
Total Liabilities | 0.64 | 0.69 | 0.62 |
Application of Funds | |||
Gross Block | 0.17 | 0.17 | 0.17 |
Capital Work in Progress | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 |
Current Assets, Loans & Advances | |||
Inventories | 0.00 | 0.00 | 0.00 |
Sundry Debtors | 0.60 | 1.25 | 1.25 |
Cash and Bank | 0.00 | 0.01 | 0.01 |
Loans and Advances | 0.13 | 0.13 | 0.11 |
Total Current Assets | 0.73 | 1.39 | 1.37 |
Current Liabilities and Provisions | |||
Current Liabilities | 0.10 | 0.71 | 0.79 |
Provisions | 0.00 | 0.00 | 0.00 |
Net Current Assets | 0.63 | 0.68 | 0.58 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | N/A | N/A | N/A |
Deferred Tax Liability | N/A | N/A | N/A |
Net Deferred Tax | N/A | N/A | N/A |
Other Assets | 0.00 | 0.00 | 0.00 |
Total Assets | 0.63 | 0.69 | 0.62 |
Quick Links for Kabra Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices